Arman Financial (ARMANFIN)
TurnaroundFairStock Score: 40/100 — MIXED
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹1,969.4 |
| Market Cap | ₹2,070.78 Cr |
| P/E Ratio | 17.89 |
| ROCE | 13.31% |
| ROE | 7.77% |
| Dividend Yield | 0% |
| Profit Growth | 405.51% |
| Debt/Equity | 1.9 |
| Sales Growth | 326.3% |
| Promoter Holding | 22% |
| 52-Week Range | ₹1,301 — ₹2,159.1 |
| Sector | Finance |
| Book Value | ₹888.88 |
Strengths
- Latest quarter net profit of ₹22 Cr on sales of ₹160 Cr shows a strong margin and improved operating leverage.
- Profit growth of 405.51% reflects a significant earnings recovery, even if from a low base.
- Piotroski F-Score of 6/9 suggests financial health is reasonable across profitability, leverage, and efficiency.
- ROCE of 13.31% is decent for an NBFC and indicates the core lending operation generates operating returns.
- Debt/Equity of 1.37 is manageable for a leveraged NBFC franchise.
Concerns
- P/E of 58.13 and P/B of 2.84 are rich compared to ROE of just 7.77%, implying the market expects a major sustained improvement.
- Sales growth of -2.85% shows the revenue base is contracting, so the profit spike may be a one-time recovery rather than durable compounding.
- Promoter holding of only 22% is low for an Indian NBFC and raises governance and alignment questions.
- Zero dividend, a FairStock score of 33/100, and a leveraged balance sheet leave little margin of safety if credit conditions worsen.
AI Analysis
At ₹1,519.50, Arman Financial carries a market cap of ₹1,648 Cr, a P/E of 58.13, and a P/B of 2.84. Benjamin Graham taught me to pay not for hope but for demonstrated earning power. Here the demonstration is thin. Sales have shrunk 2.85%, yet profit is up 405.51%. That kind of divergence usually means a low-base bounce, not a franchise compounding. The latest quarter did deliver ₹160 Cr of sales and ₹22 Cr of net profit—a strong 13.75% margin—but one quarter cannot justify a 58 multiple. Book value is ₹534.68, so I am being asked to pay 2.84 times book for a company whose ROE is only 7.77%. That fails my first test: if the business can earn only 7.77% on equity, why pay nearly three times that equity? The ROCE of 13.31% is respectable, and a Piotroski score of 6/9 suggests the balance sheet is not deteriorating. Yet debt/equity of 1.37, zero dividend, and promoter holding of just 22% do not give me the owner-operator comfort I demand. The FairStock score of 33/100 tells me this is risky. The PEG of 0.14 is seductive, but I have seen many 'cheap on future earnings' formulas destroy value when growth fades. Arman may be in early turnaround, and if recent profitability persists, the story changes. But in investing, you do not get paid for extraordinary times; you get paid for predictable ordinary times. I need more evidence, more quarters, and a higher return on equity before this becomes a candidate. For now, patience is better than speculation.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer